HomeCompareASCOF vs MRK

ASCOF vs MRK: Dividend Comparison 2026

ASCOF yields 5.11% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.1K in total portfolio value
10 years
ASCOF
ASCOF
● Live price
5.11%
Share price
$3.33
Annual div
$0.17
5Y div CAGR
-29.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$16.33
Full ASCOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ASCOF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASCOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASCOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASCOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASCOF
Annual income on $10K today (after 15% tax)
$434.44/yr
After 10yr DRIP, annual income (after tax)
$13.88/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,314.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASCOF + MRK for your $10,000?

ASCOF: 50%MRK: 50%
100% MRK50/50100% ASCOF
Portfolio after 10yr
$39.2K
Annual income
$4,907.23/yr
Blended yield
12.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ASCOF
No analyst data
Altman Z
0.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASCOF buys
0
MRK buys
0
No recent congressional trades found for ASCOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASCOFMRK
Forward yield5.11%2.76%
Annual dividend / share$0.17$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-29.8%32.7%
Portfolio after 10y$21.6K$56.8K
Annual income after 10y$16.33$9,798.13
Total dividends collected$1.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASCOF vs MRK ($10,000, DRIP)

YearASCOF PortfolioASCOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,059$358.80$11,206$366.19$147.00MRK
2$12,093$260.32$12,650$502.35$557.00MRK
3$13,127$186.77$14,407$694.19$1.3KMRK
4$14,178$133.00$16,585$967.82$2.4KMRK
5$15,265$94.25$19,342$1,363.89$4.1KMRK
6$16,400$66.58$22,913$1,947.19$6.5KMRK
7$17,595$46.93$27,662$2,823.89$10.1KMRK
8$18,860$33.03$34,159$4,173.35$15.3KMRK
9$20,203$23.23$43,337$6,308.80$23.1KMRK
10$21,634$16.33$56,776$9,798.13$35.1KMRK

ASCOF vs MRK: Complete Analysis 2026

ASCOFStock

Ascopiave S.p.A. distributes and sells natural gas in Italy. The company holds concessions and direct assignments for the supply of the service in 268 municipalities; and provides services to approximately 775,000 users through a distribution network of approximately 13,000 kilometres (km). It is also involved in the electricity distribution; heat management and co-generation activities, as well as offers integrated urban water management services in 15 municipalities that includes 100,000 inhabitants through a network of 880 km in the Province of Bergamo; and renewable energy sector with 28 hydroelectric plants and wind turbines. The company was founded in 1956 and is headquartered in Pieve di Soligo, Italy. Ascopiave S.p.A. is a subsidiary of Asco Holding S.p.A.

Full ASCOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ASCOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASCOF vs SCHDASCOF vs JEPIASCOF vs OASCOF vs KOASCOF vs MAINASCOF vs JNJASCOF vs ABBVASCOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.